Naquotinib

TypeName: Business Offer
Category:
Offer Date:2019/09/04
Country: United States
Summary: Naquotinib is an irreversible, third-generation, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity with IC50 of 8-33 nM toward EGFR mutants. https://www.bocsci.com/naquotinib-cas-1448232-80-1-item-475727.html
Description:
OfferId: 5458
Name:Alex Brown
Telphone:
Categories
No Man flag